Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PAS Effect on Tenofovir PK in Healthy Subjects
NCT03070405Phase 1Unknown
- Sponsor
- Inje University
- Start
- Oct 2016
- Primary completion
- Mar 2017
- Modality
- Small Molecules
01
Overview
Phase 1, randomised, open-label trial of 4-aminosalicylic acid in human immunodeficiency virus type 1 infection (HIV-1), Chronic Hepatitis B (CHB) and Tuberculosis (TB), sponsored by Inje University. Status: unknown.
02
Drugs
4-aminosalicylic acid
03
Conditions
human immunodeficiency virus type 1 infection (HIV-1)Chronic Hepatitis B (CHB)Tuberculosis (TB)
Beyond the preview
Go deeper on NCT03070405.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03070405.